Ji Pharma, a biopharmaceutical company specializing in innovative CAR-T cell therapy, has announced its 2026 interim performance. As of June 30, 2026, the company held... [DATA LOCKED]
UNLOCK DATA
Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals
